37
Avoro Life Sciences Fund LLC updates its Form D — $3.33B sold
Fund raise update · Hedge fund · Open-ended · Offering Indefinite · Sold $3.33B · NEW YORK, NY · filed 2025-05-02
3(c)(7) — qualified purchasers
37
Avoro Life Sciences Fund LLC updates its Form D — $3.45B sold
Fund raise update · Hedge fund · Open-ended · NEW YORK, NY · Form D/A filed 2026-05-01 · all Avoro Life Sciences vehicles
$100M+ sold3(c)(7) — qualified purchasers
Why now — by persona
Relevant to: Fund audit & tax, Fund administrator. Lead card pending.
People on the filing
| Behzad Aghazadeh | Portfolio Manager and Managing Partner of Avoro Capital Advisors LLC |
| - Avoro Capital GP, LLC | General Partner of Avoro Capital L.P. |
| - Avoro Capital Advisors LLC | Managing Member of the Issuer |
| Scott Epstein | Partner, Chief Operating Officer & Chief Compliance Officer of Avoro Capital Advisors LLC |
| Neil Cammarosano | Chief Financial Officer of Avoro Capital Advisors LLC |
| - Avoro Capital L.P. | Direct owner of Avoro Capital Advisors LLC |
Signed by Scott Epstein, Partner, COO & CCO of Avoro Capital Advisors LLC.
Placement agents / sales compensation: Far Hills Group LLC
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.